Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation

Overview of attention for article published in European Journal of Cancer (1965), May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 45 X posts from 42 X users, with an upper bound of 104,365 followers.

RT @OncologyAdvance: Long-term efficacy of anti-PD1 #immunotherapy in Hodgkin #lymphoma with and without allogenic stem cell transplantatio…

@chano_py

RT @RamonGarciaSanz: Please, provide allo-SCT to your RRHL patient! Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with an…

RT @RamonGarciaSanz: Please, provide allo-SCT to your RRHL patient! Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with an…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 41 additional X posts.